|
Feb 5
|
Vaxcyte Advances to Second Stage of Ongoing Phase 2 Study Evaluating VAX-31 for the Prevention of Invasive Pneumococcal Disease in Infants
|
|
Feb 3
|
MRK Gets Positive CHMP Nod for 21-Valent Pneumococcal Jab Capvaxive
|
|
Jan 30
|
Vaxcyte to Present at the Guggenheim SMID Cap Biotech Conference
|